gvtcx

HIV Medicines

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£89,900,000
Statuscomplete
Category (CPV) 33600000
RegionScotland
Deadline4 Feb 2026
Procedureopen
OCIDocds-h6vhtk-05ff84

Awards (14)

This procurement was awarded to 14 suppliers. Values shown are per-award; the notice total is £89,900,000.

SupplierValueDateStatus
Amarox Limited shared · · active
CST Pharma Ltd shared · · ·
Dr Reddy's Laboratories (UK) Ltd shared · · ·
Gilead Sciences Ltd shared · · active
Glenmark Pharmaceuticals Europe Ltd shared · · active
Janssen-Cilag Ltd shared · · ·
Lupin Healthcare UK Ltd shared · · active
Merck Sharp & Dohme UK Ltd shared · · ·
Milpharm Limited shared · · active
MSN Labs shared · · active
Orifarm UK Ltd shared · · active
Sun Pharma UK Ltd shared · · ·
Viatris UK Healthcare Ltd shared · · active
ViiV Healthcare UK Ltd shared · · active

description

Supply of HIV Medicines to NHS Scotland

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
5 Jan 2026 Contract notice (F02) Earlier regulations 000393-2026
7 May 2026 Contract award notice (F03) Earlier regulations 042069-2026

more from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.